ClinicalTrials.govpublic full text
A Phase 1 Study of [225Ac]-FPI-1434 Injection
advanced solid tumours, endometrial cancer, cervical cancer, ovarian cancer, breast cancer, triple negative breast cancer (tnbc), her2-negative breast cancer, head and neck squamous cell carcinoma (hnscc), adrenocortical carcinoma, uveal melanoma, 225-ac labelled humanized monoclonal antibody against igf-1r, [225ac]-fpi-1434
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 859603
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.